Decreased androgen levels and improved menstrual pattern after angiotensin II receptor antagonist telmisartan treatment in four hypertensive patients with polycystic ovary syndrome: case series - Wikidata - awgldk - TriplyDB

Decreased androgen levels and improved menstrual pattern after angiotensin II receptor antagonist telmisartan treatment in four hypertensive patients with polycystic ovary syndrome: case series

Decreased androgen levels and improved menstrual pattern after angiotensin II receptor antagonist telmisartan treatment in four hypertensive patients with polycystic ovary syndrome: case series

http://www.wikidata.org/entity/Q24645442

about

Sex differences in adaptive downregulation of pre-macula densa sodium transporters with ANG II infusion in mice.Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome.PHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Insulin action and lipotoxicity in the development of polycystic ovary syndrome: A review.Role of Lipotoxicity and Contribution of the Renin-Angiotensin System in the Development of Polycystic Ovary Syndrome.

P2860

Q33589088-A6E47EFE-FE9E-40E5-BD9C-9F0319CE6E8C Q34979189-13D2CD60-8F82-4EE3-9237-DE52E1A41C55 Q38861206-D3E95671-E353-4D45-89B6-9427910AD56F Q55403020-C298C8DC-B18D-420B-9693-29E3AE2FFFD5

P2860

Decreased androgen levels and improved menstrual pattern after angiotensin II receptor antagonist telmisartan treatment in four hypertensive patients with polycystic ovary syndrome: case series

http://www.wikidata.org/entity/Q24645442

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Decreased androgen levels and ...... ic ovary syndrome: case series

@ast

Decreased androgen levels and ...... ic ovary syndrome: case series

@en

Decreased androgen levels and ...... ic ovary syndrome: case series

@nl

type

label

Decreased androgen levels and ...... ic ovary syndrome: case series

@ast

Decreased androgen levels and ...... ic ovary syndrome: case series

@en

Decreased androgen levels and ...... ic ovary syndrome: case series

@nl

prefLabel

Decreased androgen levels and ...... ic ovary syndrome: case series

@ast

Decreased androgen levels and ...... ic ovary syndrome: case series

@en

Decreased androgen levels and ...... ic ovary syndrome: case series

@nl

P1433

Q24645442-3602579B-D88B-49D2-BA9C-615365A42939

P1476

Q24645442-243BBFA0-9063-4375-9CA1-C785DCB3B39C

P2093

Q24645442-2D91D568-8E93-4079-842B-8E82CF52D755

Q24645442-3C4F60FC-DE61-47E1-9D07-A3889465525D

Q24645442-5E7B7B02-063D-46A5-B2E1-BF05BF65CFD5

Q24645442-661D1283-FE45-42F0-979E-623765A9284C

Q24645442-93304D62-72EA-4D50-8953-3A0E64582D00

Q24645442-AEEDE88A-96F5-485B-9223-CF820798B977

Q24645442-D9F4EB88-4ECE-45F2-A177-2371F0EA17E2

P2860

Q24645442-04F568C2-BA7F-4009-B328-A4CB6ADEB59F

Q24645442-09269F0D-4CD7-45CF-AE43-9A8F9392B9B6

Q24645442-2528F84C-A7E8-4E1A-A7E6-01B5331DC1FF

Q24645442-25914BC5-0533-4377-A0A5-2C69219B3046

Q24645442-2A9AABA7-C8B6-4190-9A32-E001CE7CEA49

Q24645442-398E601C-1CB6-423C-B533-B7C8B972F81B

Q24645442-3CC9401A-DE58-47F9-B671-41560E76811E

Q24645442-4483C463-116A-4083-95AB-E4131479B363

Q24645442-4ADAFB5C-F4DA-48ED-82F5-D9AC678347D7

Q24645442-515874DA-969B-483C-8A29-71F71E79974A

P304

Q24645442-9CFAC17C-111D-4DCB-843F-F8807A0FF8BB

P31

Q24645442-774B58E1-5895-4BAC-B0A4-8475CC3D055B

Q24645442-f406306b-1d46-49bb-b638-17fb6de3e98c

P356

Q24645442-570611AD-4465-4760-85E7-20C38FF8722D

P407

Q24645442-4979284B-34AE-4B76-BA8B-E61695253C52

P433

Q24645442-3EFE00CC-5E75-488D-903C-1742435679F6

P478

Q24645442-2C833FB7-0A58-4B3C-BE9C-EF3E87B3C2FF

P577

Q24645442-4D0E1F8D-922A-452F-9B7E-736D68190E1C

P5875

Q24645442-36F874AD-1644-47C2-8621-4BE607A62EE2

P698

Q24645442-E9011854-7FD8-46D4-88E4-2773323C6D28

P921

Q24645442-1F245BD1-036D-464F-A7B2-F813BC3A0C1E

Q24645442-C1654423-4405-45AE-9CB2-60C7B2EB1C44

P932

Q24645442-A7ADB495-FDC3-4513-AE12-E5B355465813

P356

P1433

Croatian Medical Journal

P1476

Decreased androgen levels and ...... ic ovary syndrome: case series

@en

P2093

Andrej Janez

http://www.w3.org/2001/XMLSchema#string

Bojan Vrtovec

http://www.w3.org/2001/XMLSchema#string

Helena Meden-Vrtovec

http://www.w3.org/2001/XMLSchema#string

Janez Prezelj

http://www.w3.org/2001/XMLSchema#string

Marija Pfeifer

http://www.w3.org/2001/XMLSchema#string

Mojca Jensterle

http://www.w3.org/2001/XMLSchema#string

Tomaz Kocjan

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin in polycystic ovary syndrome: systematic review and meta-analysis

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells.

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity.

Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome.

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.

A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome.

Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system.

P304

864-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3325/CMJ.2007.6.864

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5774865

http://www.w3.org/2001/XMLSchema#string

P698

18074422

http://www.w3.org/2001/XMLSchema#string

P921

Amzerioù (merc'hed)

polycystic ovary syndrome

P932

2213810

http://www.w3.org/2001/XMLSchema#string